H

Henlius Tech Stack

Oncology biopharmaceutical manufacturer scaling biosimilars and mAbs globally

Biotechnology Research Shanghai, Shanghai 1,001–5,000 employees Founded 2010 Public Company

Henlius manufactures and distributes oncology treatments across ~60 countries, serving over 950,000 patients. The company is actively expanding internationally (joint ventures, multi-country hiring, clinical trial infrastructure) while adopting ML tooling (PyTorch, TensorFlow, XGBoost) to accelerate drug development—signaling a shift toward computational chemistry and patient recruitment optimization. Leadership gaps in R&D execution and regulatory compliance dominate their active projects and pain-point backlog, suggesting resource constraints in scaling manufacturing and clinical operations.

Tech Stack 16 technologies

Core StackSAS Python PyTorch TensorFlow Docker Kubernetes Word Excel Outlook SharePoint R Alibaba Cloud Git bash XGBoost

What Henlius Is Building

◆Challenges

Risk mitigation
Ensuring compliance with fda and health canada regulations
Managing medicinal product safety profile
Implementing regulatory changes
Managing study timelines and budgets
Overseas expansion compliance
Clinical trial regulatory compliance
Accelerating patient recruitment
Study timeline management
R&d success rate improvement

▲Active Projects

Post-authorization safety studies protocol review
Implementation of regulatory changes
Review of pv system deviations and capas
Overseas joint venture establishment
International clinical trial support
Product licensing negotiations
Patient recruitment plan development
Clinical study site selection
Ai-assisted drug development
In-silico tool platform

Hiring Activity

Steady10 roles · 4 in 30d

Department

Healthcare

3

Research

3

Engineering

1

Executive

1

Legal

1

Seniority

Senior

6

Director

1

Lead

1

Mid

1

Notable leadership hires: Chief Commercial Officer Assistant

Company intelligence

Find more companies like Henlius by tech stack, pain points and active projects

Get started free

About Henlius

Henlius is a Shanghai-headquartered public biopharmaceutical company founded in 2010, operating at ~1,000–5,000 employees. The company develops, manufactures, and distributes monoclonal antibodies, biosimilars, and antibody-drug conjugates focused on oncology, immunology, and autoimmune diseases. International expansion is a near-term priority—active projects include overseas joint-venture formation, multi-country clinical trial support, and regulatory harmonization across FDA and Health Canada frameworks. Current hiring spans healthcare, research, engineering, and executive functions across the United States, Singapore, China, and Belgium.

HeadquartersShanghai, Shanghai

Company Size1,001–5,000 employees

Founded2010

Hiring MarketsUnited States, Singapore, China, Belgium

Frequently Asked Questions

What tech stack does Henlius use?

Core tools include Python, R, PyTorch, TensorFlow, and XGBoost for research; Docker and Kubernetes for infrastructure; SAS for statistical analysis; and Alibaba Cloud for hosting. Also uses standard enterprise software: Word, Excel, Outlook, SharePoint.

What is Henlius working on?

Projects include AI-assisted drug development, in-silico modeling tools, international clinical trial support, post-authorization safety studies, patient recruitment automation, and overseas joint-venture establishment to expand oncology treatment distribution.